Francesco Luzza

30PUBLICATIONS
73CO-AUTHORS
Metabolic medicineApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical biochemistry - lipidsBehavioural epidemiologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (30)

|May 27, 2026
Metabolic Dysfunction-Associated Steatotic Liver Disease and Incretin Receptor Agonists: A Metabolic Approach to Halting Liver Disease Progression.

|Nov 13, 2025
Upadacitinib's Effectiveness and Safety as a Second- or Third-Line Therapy in Patients with Ulcerative Colitis: Data from a Real-World Study.

Giammarco Mocci, Antonio Tursi, Franco Scaldaferri

|Oct 28, 2025
Gut Microbiota Changes in Metabolic Dysfunction-Associated Steatohepatitis and Inflammatory Bowel Disease: Common Pathogenic Features.

Giuseppe Guido Maria Scarlata, Domenico Morano, Abdulrahman Ismaiel

|May 14, 2025
Use of Metabolic Scores and Lipid Ratios to Predict Metabolic Dysfunction-Associated Steatotic Liver Disease Onset in Patients with Inflammatory Bowel Diseases.

Ludovico Abenavoli, Giuseppe Guido Maria Scarlata, Massimo Borelli

|Dec 17, 2024
Long-Term Effectiveness and Safety of Ustekinumab in Crohn's Disease: Results from a Large Real-Life Cohort Study.

Giammarco Mocci, Antonio Tursi, Franco Scaldaferri

|Nov 27, 2024
Use of Non-Invasive Biomarkers and Clinical Scores to Predict the Complications of Liver Cirrhosis: A Bicentric Experience.

Giuseppe Guido Maria Scarlata, Abdulrahman Ismaiel, Maria Luisa Gambardella

Pageof 5

Frequent Collaborators

24 joint publications

Ludovico Abenavoli

12 joint publications

Luigi Boccuto

12 joint publications

Giuseppe Guido Maria Scarlata

11 joint publications

Rocco Spagnuolo